Induction of immunity in the respiratory tract and protection from bovine herpesvirus type 1 infection by different routes of immunization with recombinant adenovirus

Viral Immunology

Volumn 11, Issue 2, 1998, Pages 79-91

  Papp, Zsuzsanna ^a   Babiuk, Lorne A ^a   Baca Estrada, Maria E ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; HERPES VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; FEMALE; HUMAN ADENOVIRUS 5; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INTRADERMAL DRUG ADMINISTRATION; INTRADUODENAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUNG; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN EXPRESSION; RAT; SECRETORY CELL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; BOVINAE; BOVINE HERPESVIRUS 1; GOSSYPIUM HIRSUTUM; HERPES; HERPESVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; SIGMODON;

EID: 0031671014     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.79     Document Type: Article

References (45)

1. Baca-Estrada, M.E., X. Liang, L.A. Babiuk, and D. Yoo. 1995. Induction of mucosal immunity in cotton rats to hemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus. Immunology 86:134-140.
2. Bender, B.S., C.A. Rowe, S.F. Taylor, L.S. Wyatt, B. Moss, and P.A. Small, Jr. 1996. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J. Virol. 70:6418-6424.
3. Both, G.W., L.J. Lockett, V. Janardhana, S.J. Edwards, A.R. Bellamy, F.L. Graham, and L. Prevec. 1993. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single-dose of a recombinant adenovirus expressing rotaavirus VP7sc. Virology 193:940-950.
4. Breker-Klassen, M.M., D. Yoo, S.K. Mittal, S.D. Sorden, D.M. Haines, and L.A. Babiuk. 1995. Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Siginodon hispidus cotton rats from bovine parainfluenza virus type 3 infection. J. Virol. 69:4308-4315.
5. Charlton, K.M., M. Artois, L. Prevec, J.B. Campbell, G.A. Casey, A.I. Wandeler, and J. Armstrong. 1992. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch. Virol. 123:169-179.
6. Chengalvala, M.V., B.M. Bhat, R.A. Bhat, S.K. Dheer, M.D. Lubeck, R.H. Purcell, and K.K. Murthy. 1997. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine 15:335-339.
7. Collins, P.L., G.A. Prince, E. Camargo, R.H. Purcell, R.M. Chanock, and B.R. Murphy. 1990. Evaluation of the protective efficacy of recombinant vaccinia viruses and adenoviruses that express respiratory cyncytial virus glycoproteins, p. 79-84. In F. Brown, R.M. Chanock, H. Ginsberg, R.A. Lerner (ed.): Vaccines: Modem Approaches to New Vaccines including Prevention of AIDS. Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York.
8. Eis Hubinger, A.M., D.S. Schmidt, and K.E. Schneweis. 1993. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:379-385.
9. Gallichan, W.S., D.C. Johnson, F.L. Graham, and K.L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein. B. J. Infect. Dis. 168:622-629.
10. Graham, F.L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In E.J. Murray (ed.): Methods in Molecular Biology, Vol. 7: Gene Transfer and Expression Protocols. The Humana Press, Clifton, New Jersey.
11. Hillam, R.P., D.E. Bice, and B.A. Muggenburg. 1985. Lung localization of antibody-forming cells stimulated in distant peripheral lymph nodes. Immunology 55:257-261.
12. Hsu, K.-H.L., M.D. Lubeck, B.M. Bhat, R.A. Bhat, B. Kostek, B.H. Selling, S. Mizutani, A.R. Davis, and P.P. Hung. 1994. Efficacy of adenovirus-vectored respiratory cyncytial virus vaccines in a new ferret model. Vaccine 12:607-612.
13. Hsu, K.-H.L., M.D. Lubeck, A.R. Davis, R.A. Bhat, B.H. Selling, B.M. Bhat, S. Mizutani, B.R. Murphy, P.L. Collins, R.M. Chanock, and P.P. Hung. 1992. Immunogenecity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. J. Infect. Dis. 166: 769-775.
14. Huard, J., H. Lochmuller, G. Acsadi, A. Jani, B. Massie, and G. Karpati. 1995. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:107-115.
15. Imler, J.-L. 1995. Adenovirus vectors as recombinant viral vaccines. Vaccine 13:1143-1151.
16. Kanesaki, T., B.R. Murphy, P.L. Collins, and P.L. Ogra. 1991. Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory cyncytial virus. J. Virol. 65:657-663.
17. Kowalski, J., S.A. Gilbert, S. van Drunen Littel-van den Hurk, J. van den Hurk, L.A. Babiuk, and T.J. Zamb. 1993. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11:1100-1107.
18. Kraehenbuhl, J.-P., and M.R. Neutra. 1994. Monoclonal secretory IgA for protection of the intestinal mucosa against viral and bacterial pathogens, pp. 403-414. In P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock (eds.): Handbook of Mucosal Immunology. Academic Press, San Diego, California.
19. Lipscomb, M.F., D.E. Bice, C.R. Lyons, M.R. Schuyler, and D. Wilkes. 1995. The regulation of pulmonary immunity. Adv. Immunol. 59:369-455.
20. Lubeck, M.D., A.R. Davis, M. Chengalvala, R.J. Natuk, J.E. Morin, K. Molnar-Kimber, B.B. Mason, B.M. Bhat, S. Mizutani, P.P. Hung, and R.H. Purcell. 1989. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc. Natl. Acad. Sci. USA. 86:6763-6767.
21. McGhee, J.R., J. Mestecky, M.T. Detzbaugh, J.H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
22. Mestecky, J., R. Abraham, and P.L. Ogra. 1994. Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surfaces, pp. 357-372. In P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock (eds.): Handbook of Mucosal Immunology. Academic Press, San Diego, California.
23. Michalek, S.M., J.H. Eldridge, R. Curtiss III, and K.L. Rosenthal. 1994. Antigen delivery systems: new approaches to mucosal immunization, pp. 373-390. In P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock (eds): Handbook of Mucosal Immunology. Academic Press, San Diego, California.
24. Misra, V., R.M. Blumenthal, and L.A. Babiuk. 1981. Proteins specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J. Virol. 40:1046-1054.
25. Mittal, S.K., M.R. McDermott, D.C. Johnson, L. Prevec, and F.L. Graham. 1993. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28:67-90.
26. Mittal, S.K., Z. Papp, S.K. Tikoo, M.E. Baca-Estrada, D. Yoo, M. Benko, and L.A. Babiuk. 1996. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222:299-309.
27. Morin, J.E., M.D. Lubeck, J.E. Barton, A.J. Conley, A.R. Davis, and P.P. Hung. 1987. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc. Natl. Acad. Sci. USA. 84:4626-4630.
28. Murphy, B.R. 1994. Mucosal immunity to viruses, pp. 333-339. In P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock (eds.): Handbook of Mucosal Immunology. Academic Press, San Diego, California.
29. Oualikene, W., P. Gonin, and M. Eloit. 1994. Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species. J. Gen. Virol. 75:2765-2768.
30. Pacini, D.L., E.J. Dubovi, and W.A. Clyde. 1984. A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 150:92-97.
31. Papp, Z., D.M. Middleton, S.K. Mittal, L.A. Babiuk, and M.E. Baca-Estrada. 1997. Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection. J. Gen. Virol. 78:2933-2943.
32. Phillips-Quagliata, J.M., and M.E. Lamm. 1994. Lymphocyte homing to mucosal effector sites, pp. 225-242. In P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock (eds.): Handbook of Mucosal Immunology. Academic Press, San Diego, California.
33. Prevec, L.,M. Schneider, K.L. Rosenthal, L.W. Belbeck, J.B. Derbyshire, and F. L. Graham. 1989. Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70:429-434.
34. Rosenthal, K.L., K.F.T. Copeland, and W.S. Gallichan. 1996. Recombinant adenoviruses as vectors for mucosal immunity, pp. 147-158. In H. Kiyono, P.L. Ogra, and J.R. McGhee (eds.), Mucosal Vaccines. Academic Press, San Diego, California.
35. Sangster, M.Y., X.Y. Mo, R. Sealy, and C. Coleclough. 1997. Matching antibody class with pathogen type and portal of entry. J. Immunol. 159:1893-1902.
36. Schwartz, A.R., Y. Togo, and R.B. Hornick. 1974. Clinical evaluation of live, oral types 1, 2, and 5 adenovirus vaccines. Am. Rev. Respir. Dis. 109:233-238.
37. Stratford-Perricaudet, L.D., M. Levrero, J.F. Chasse, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:241-256.
38. Tacket, C.O., G. Losonsky, M.D. Lubeck, A.R. Davis, S. Mizutani, G. Horwith, P. Hung, R. Edelman, and M.M. Levine. 1992. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine 10:673-676.
39. Tamura, S.-I., and T. Kurata. 1996. Intranasal immunisation with influenza vaccine, pp. 425-436. In H. Kiyono, P.L. Ogra, and J.R. McGhee (eds.): Mucosal Vaccines. Academic Press, San Diego, California.
40. Top, F.H., Jr., E.L. Buescher, W.H. Bancroft, and P.K. Russell. 1971. Immunization with live types 7 and 4 ade-novirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J. Infect. Dis. 124:155-160.
41. Top, F.H., Jr., R.A. Grossmann, P.J. Bartelloni, H.E. Segal, B.A. Dudding, P.K. Russell, and E.L. Buescher. 1971. Immunization with live types 7 and 4 adenovirus vaccines. I. Infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Infect. Dis. 124:148-154.
42. van Drunen Littel-van den Hurk, S., J.V. van den Hurk, J.E. Gilchrist, V. Misra, and L.A. Babiuk. 1984. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135:466-479.
43. VanCott, J.L., T.A. Brim, J.K. Lunney, and L.J. Saif. 1994. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J. Immunol. 152:3980-3990.
44. Wagner, D.K., M.L. Clements, C.B. Reimer, M.H. Snyder, D.L. Nelson, and B.R. Murphy. 1987. Analysis of IgG antibody responses after live and inactivated influenza A vaccine indicates that nasal wash IgG is a transudate from serum. J. Clin Microbiol. 25:559-562.
45. Zabner, J., D.M. Petersen, A.P. Puga, S.M. Graham, L.A. Couture, L.D. Keyes, M.J. Lukason, J.A. St. George, R.J. Gregory, A.E. Smith, and M.J. Welsh. 1994. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet 6:75-83.